Dr Agarwal’s Health Care’s upcoming listing worries investors due to a discounted grey market premium and muted subscription. Despite being India’s largest eye care chain, with a 25% market share in FY24, and significant revenue and efficiency growth, market conditions appear challenging. Analysts recommend a long-term investment view for potential gains.
Positive Breakout: These 3 stocks cross above their 200 DMAs
In the NSE Midcap pack, three stocks’ close prices crossed above their 200 DMA (Daily Moving Averages) on February 5, according to stockedge.com’s technical scan